CCL2 and colitis: Consistent with these, our data showed that the expression of TNF-α, MCP-1, IL-6, IL-1β, and MPO activity was significantly increased in pancreas and colon of the model group, while formononetin treatment downregulated their levels, indicating formononetin ameliorated AP and associated colonic inflammation.